Clinical Trials
6 trialsNCT07089992 2026-05-14
A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT07169344 2026-01-28
PROSARC-1
Oslo University Hospital
Phase 2 Recruiting
NCT07173972 2026-01-28
PROSARC-2
Oslo University Hospital
Phase 2 Recruiting
NCT06849986 2026-01-08
TAIS
Fudan University
Phase 2 Recruiting
NCT06389799 2025-08-28
PERELI
Lund University Hospital
Phase 2 Recruiting
NCT06277154 2025-07-24
MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
HRYZ Biotech Co.
Phase 2 Recruiting